drugset / Trial / NCT05861648

Folic Acid Supplementation in Calcific Aortic Valve Disease

NCT05861648

RandomizedParallel-groupDouble-blindPrevention

Summary

This is a prospective, randomized, comparative, clinical trial conducted by Wuhan Union Hospital that aims to evaluate the efficacy and safety of folic acid compared to placebo in patients with calcific aortic valve disease with mild aortic valve stenosis.

Timeline

Start
2023-07-01
Primary completion
2025-07-01
Completion
2028-07-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject folic acid Other / unclassified 2.5 mg Oral